Roles
- (Leader) Adverse Effects Methods Group
1. Financial interests
Yes
Please specify
I have received consulting fees from Syri Pharmaceuticals and Adalvo Pharmaceuticals for expert opinion/ testimony on regulatory issues surrounding generic formulations.
2. Non-financial interests
No
3. Do you hold any financial or non-financial ties with the Cochrane Collaboration, past or present
No
4. Commercial organisation with an interest in any topic related to health care or medical research
No
